Answers are grounded in this paper and cite their sources.
Well‐being, physical capacity, growth and development, emotional stability, and even clinical symptoms such as thirst and polyuria, appear to be rather insensitive parameters of control in young patients with insulin‐dependent diabetes mellitus (IDDM), reflecting only inadequately the actual state of health and the current metabolic condition. An effective supervision of the adequacy of treatment requires periodic physical checkups by an expert physician and permanent (i.e. daily) monitoring of the metabolic state by the patient himself. Of all accessible metabolic parameters, blood glucose and urinary glucose excretion seem to be most important, reflecting best the usually wide range of metabolic fluctuations during the day. Both can easily be measured repeatedly, using semiquantitative method and interpreted by the patient. However, only if adequate consequences such as necessary changes in therapy are taken, this sort of self‐monitoring is useful. Furthermore, the patient needs to be assured that his own measurements are correct, by both laboratory controls and by determinations of glycosylated proteins, in particular HbA 1 , which integrate glycaemia during his red cells' life span and are well suited to complement self‐monitoring. Compared to glucose, blood lipids, urinary ketone bodies, and C‐peptide or free insulin concentrations only serve as additional parameters of more limited importance, most of which require laboratories and are not available for every‐day therapeutic decisions.
No takes yet. Share an insight, caveat, or question.
Bruno Weber (1984) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: